Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A. Hanley

Showing results (61-70 of 176) with videos related to

Pageof 18
Sort By:
The Journal of Clinical Endocrinology and Metabolism|November 7, 2003
Efficacy and safety of human parathyroid hormone-(1-84) in increasing bone mineral density in postmenopausal osteoporosisAnthony B Hodsman, David A Hanley, Mark P Ettinger, et al.
JAMA|August 27, 2009
Trends in hip fracture rates in CanadaWilliam D Leslie, Siobhan O'Donnell, Sonia Jean, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 19, 2008
Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agentsClaudie Berger, Lisa Langsetmo, Lawrence Joseph, et al.
BMC Musculoskeletal Disorders|January 30, 2010
Dietary patterns in Canadian men and women ages 25 and older: relationship to demographics, body mass index, and bone mineral densityLisa Langsetmo, Suzette Poliquin, David A Hanley, et al.
BMC Musculoskeletal Disorders|June 22, 2011
A randomized controlled trial of vitamin D dosing strategies after acute hip fracture: no advantage of loading doses over daily supplementationAlexandra Papaioannou, Courtney C Kennedy, Lora Giangregorio, et al.
BMC Nephrology|August 8, 2014
The VITAH trial VITamin D supplementation and cardiac Autonomic tone in Hemodialysis: a blinded, randomized controlled trialMichelle C Mann, Derek V Exner, Brenda R Hemmelgarn, et al.
Postgraduate Medicine|May 31, 2022
The role of osteoanabolic agents in the management of patients with osteoporosisMichael R McClung, Micol S Rothman, E Michael Lewiecki, et al.
The American Journal of Medicine|June 2, 2019
Western Osteoporosis Alliance Clinical Practice Series: Treat-to-Target for OsteoporosisE Michael Lewiecki, David L Kendler, K Shawn Davison, et al.
The Journal of Clinical Endocrinology and Metabolism|November 21, 2019
Safety of High-Dose Vitamin D Supplementation: Secondary Analysis of a Randomized Controlled TrialEmma O Billington, Lauren A Burt, Marianne S Rose, et al.
Scientific Reports|June 2, 2026
An explainable machine learning approach to predict fragility fractures and the identification of important featuresSayem Borhan, Alexandra Papaioannou, Jonathan Adachi, et al.
Pageof 18

Showing results (61-70 of 176) with videos related to

Sort By:
Pageof 18
The Journal of Clinical Endocrinology and Metabolism|November 7, 2003
Efficacy and safety of human parathyroid hormone-(1-84) in increasing bone mineral density in postmenopausal osteoporosisAnthony B Hodsman, David A Hanley, Mark P Ettinger, et al.
JAMA|August 27, 2009
Trends in hip fracture rates in CanadaWilliam D Leslie, Siobhan O'Donnell, Sonia Jean, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 19, 2008
Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agentsClaudie Berger, Lisa Langsetmo, Lawrence Joseph, et al.
BMC Musculoskeletal Disorders|January 30, 2010
Dietary patterns in Canadian men and women ages 25 and older: relationship to demographics, body mass index, and bone mineral densityLisa Langsetmo, Suzette Poliquin, David A Hanley, et al.
BMC Musculoskeletal Disorders|June 22, 2011
A randomized controlled trial of vitamin D dosing strategies after acute hip fracture: no advantage of loading doses over daily supplementationAlexandra Papaioannou, Courtney C Kennedy, Lora Giangregorio, et al.
BMC Nephrology|August 8, 2014
The VITAH trial VITamin D supplementation and cardiac Autonomic tone in Hemodialysis: a blinded, randomized controlled trialMichelle C Mann, Derek V Exner, Brenda R Hemmelgarn, et al.
Postgraduate Medicine|May 31, 2022
The role of osteoanabolic agents in the management of patients with osteoporosisMichael R McClung, Micol S Rothman, E Michael Lewiecki, et al.
The American Journal of Medicine|June 2, 2019
Western Osteoporosis Alliance Clinical Practice Series: Treat-to-Target for OsteoporosisE Michael Lewiecki, David L Kendler, K Shawn Davison, et al.
The Journal of Clinical Endocrinology and Metabolism|November 21, 2019
Safety of High-Dose Vitamin D Supplementation: Secondary Analysis of a Randomized Controlled TrialEmma O Billington, Lauren A Burt, Marianne S Rose, et al.
Scientific Reports|June 2, 2026
An explainable machine learning approach to predict fragility fractures and the identification of important featuresSayem Borhan, Alexandra Papaioannou, Jonathan Adachi, et al.
Pageof 18